Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Benitec Biopharma Debt to Equity Ratio 2014-2019 | BNTC

Current and historical debt to equity ratio values for Benitec Biopharma (BNTC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Benitec Biopharma debt/equity for the three months ending December 31, 2019 was 0.02.
  
Benitec Biopharma Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-12-31 $0.00B $0.02B 0.02
2017-09-30 $0.00B $0.02B 0.00
2016-09-30 $0.00B $0.02B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.02B 0.00
2015-12-31 $0.00B $0.02B 0.00
2015-06-30 $0.00B $0.02B 0.00
2014-12-31 $0.00B $0.03B 0.00
2014-06-30 $0.00B $0.03B 0.00
2013-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.009B $0.013B
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.998B 11.09
Amgen (AMGN) United States $141.574B 15.38
CSL (CSLLY) Australia $92.626B 0.00
Gilead Sciences (GILD) United States $86.306B 12.43
Vertex Pharmaceuticals (VRTX) United States $70.548B 39.37
Regeneron Pharmaceuticals (REGN) United States $67.370B 24.91
Illumina (ILMN) United States $50.589B 58.43
Biogen (BIIB) United States $46.421B 7.94
Seattle Genetics (SGEN) United States $27.629B 0.00
Moderna (MRNA) United States $27.432B 0.00
Genmab (GMAB) Denmark $23.773B 19.56
Alexion Pharmaceuticals (ALXN) United States $22.527B 9.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.281B 0.00
Genmab (GNMSF) Denmark $21.968B 65.22
BioMarin Pharmaceutical (BMRN) United States $21.403B 155.29
Incyte (INCY) United States $20.606B 0.00
BeiGene (BGNE) Cayman Islands $19.054B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.852B 0.00
BioNTech SE (BNTX) Germany $15.637B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Horizon Therapeutics Public (HZNP) Ireland $14.999B 35.10
Exact Sciences (EXAS) United States $13.087B 0.00
Galapagos (GLPG) Belgium $12.406B 44.95
Sarepta Therapeutics (SRPT) United States $12.404B 0.00
QIAGEN (QGEN) Netherlands $11.028B 27.99
ARGENX SE-ADR (ARGX) Netherlands $10.912B 0.00
Bio-Techne Corp (TECH) United States $10.069B 69.69
Immunomedics (IMMU) United States $9.389B 0.00
Guardant Health (GH) United States $8.626B 0.00
Novavax (NVAX) United States $7.624B 0.00
Repligen (RGEN) United States $7.504B 119.11
Ascendis Pharma (ASND) Denmark $7.451B 0.00
Emergent Biosolutions (EBS) United States $6.857B 27.16
Exelixis (EXEL) United States $6.755B 24.56
Vir Biotechnology (VIR) United States $6.717B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.407B 198.50
SWEDISH ORP BIO (BIOVF) Sweden $6.375B 15.86
ACADIA Pharmaceuticals (ACAD) United States $6.285B 0.00
Mirati Therapeutics (MRTX) United States $5.861B 0.00
Acceleron Pharma (XLRN) United States $5.522B 0.00
MyoKardia (MYOK) United States $5.381B 0.00
Adaptive Biotechnologies (ADPT) United States $5.209B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.078B 0.00
Zai Lab (ZLAB) China $4.628B 0.00
NeoGenomics (NEO) United States $4.413B 1332.00
MorphoSys AG (MOR) Germany $4.282B 56.12
China Biologic Products (CBPO) China $4.175B 23.21
Blueprint Medicines (BPMC) United States $4.100B 0.00
Bluebird Bio (BLUE) United States $4.091B 0.00
Halozyme Therapeutics (HALO) United States $3.913B 0.00
Amicus Therapeutics (FOLD) United States $3.783B 0.00
Global Blood Therapeutics (GBT) United States $3.782B 0.00
Arena Pharmaceuticals (ARNA) United States $3.659B 0.00
Reata Pharmaceuticals (RETA) United States $3.434B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.417B 0.00
Denali Therapeutics (DNLI) United States $3.174B 0.00
Sorrento Therapeutics (SRNE) United States $3.004B 0.00
Insmed (INSM) United States $3.002B 0.00
Fate Therapeutics (FATE) United States $2.962B 0.00
Alkermes (ALKS) Ireland $2.960B 62.03
Principia Biopharma (PRNB) United States $2.900B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.644B 0.00
Amarin (AMRN) Ireland $2.552B 0.00
Twist Bioscience (TWST) United States $2.544B 0.00
Inovio Pharmaceuticals (INO) United States $2.303B 0.00
Editas Medicine (EDIT) United States $2.164B 0.00
Viela Bio (VIE) United States $1.959B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
UniQure (QURE) Netherlands $1.846B 0.00
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 60.74
Seres Therapeutics (MCRB) United States $1.797B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.762B 0.00
I-Mab (IMAB) China $1.675B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Eidos Therapeutics (EIDX) United States $1.633B 0.00
Revance Therapeutics (RVNC) United States $1.623B 0.00
Cytokineticsorporated (CYTK) United States $1.545B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.466B 0.00
Zealand Pharma (ZEAL) Denmark $1.423B 0.00
Zymeworks (ZYME) Canada $1.382B 0.00
Mesoblast (MESO) Australia $1.379B 0.00
Coherus BioSciences (CHRS) United States $1.351B 7.88
Forma Therapeutics Holdings (FMTX) United States $1.326B 0.00
Intra-Cellular Therapies (ITCI) United States $1.302B 0.00
Epizyme (EPZM) United States $1.293B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
NGM Biopharmaceuticals (NGM) United States $1.261B 0.00
Mersana Therapeutics (MRSN) United States $1.244B 0.00
REGENXBIO (RGNX) United States $1.215B 0.00
Adverum Biotechnologies (ADVM) United States $1.202B 0.00
Compugen (CGEN) Israel $1.201B 0.00
Intellia Therapeutics (NTLA) United States $1.199B 0.00
Akcea Therapeutics (AKCA) United States $1.158B 0.00
Alcobra (ARCT) United States $1.153B 0.00
Beam Therapeutics (BEAM) United States $1.147B 0.00
Arcus Biosciences (RCUS) United States $1.139B 0.00
Arvinas (ARVN) United States $1.084B 0.00
Alector (ALEC) United States $1.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.029B 0.00
NantKwest (NK) United States $1.005B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.976B 0.00
Myriad Genetics (MYGN) United States $0.974B 50.27
Heska (HSKA) United States $0.965B 0.00
Athenex (ATNX) United States $0.949B 0.00
Retrophin (RTRX) United States $0.937B 0.00
Morphic Holding (MORF) United States $0.858B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.838B 0.00
Castle Biosciences (CSTL) United States $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Pharming Group (PHGUF) Netherlands $0.807B 18.43
Cara Therapeutics (CARA) United States $0.798B 0.00
Codexis (CDXS) United States $0.791B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
Intrexon (PGEN) United States $0.748B 0.00
Frequency Therapeutics (FREQ) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.713B 0.00
Vericel (VCEL) United States $0.711B 0.00
Kadmon Holdings (KDMN) United States $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.695B 0.00
MiMedx (MDXG) United States $0.686B 0.00
Biofrontera AG (BFRA) Germany $0.684B 0.00
Agenus (AGEN) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.651B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.650B 5.69
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.586B 0.00
Syros Pharmaceuticals (SYRS) United States $0.554B 0.00
MeiraGTx Holdings (MGTX) United States $0.532B 0.00
Kala Pharmaceuticals (KALA) United States $0.512B 0.00
Anika Therapeutics (ANIK) United States $0.507B 22.16
Prothena (PRTA) Ireland $0.503B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Innate Pharma S.A (IPHA) France $0.482B 0.00
Cel-Sci (CVM) United States $0.480B 0.00
Protagonist Therapeutics (PTGX) United States $0.467B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.462B 32.68
Aquinox Pharmaceuticals (NLTX) United States $0.460B 0.00
Athersys (ATHX) United States $0.456B 0.00
Avid Bioservices (CDMO) United States $0.455B 0.00
AC Immune SA (ACIU) Switzerland $0.451B 0.00
Pfenex (PFNX) United States $0.442B 0.00
Clovis Oncology (CLVS) United States $0.431B 0.00
Prometic Life Sciences (LMNL) Canada $0.414B 0.00
Scholar Rock Holding (SRRK) United States $0.394B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.394B 0.00
ANI Pharmaceuticals (ANIP) United States $0.390B 9.19
PDL BioPharma (PDLI) United States $0.377B 0.00
Merus (MRUS) Netherlands $0.377B 0.00
Cellular Biomedicine (CBMG) United States $0.374B 0.00
MannKind (MNKD) United States $0.374B 0.00
Albireo Pharma (ALBO) United States $0.367B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.366B 0.00
Kamada (KMDA) Israel $0.358B 17.13
Precision BioSciences (DTIL) United States $0.346B 0.00
WAVE Life Sciences (WVE) Singapore $0.339B 0.00
Geron (GERN) United States $0.333B 0.00
CytomX Therapeutics (CTMX) United States $0.327B 0.00
Trevena (TRVN) United States $0.301B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
ChromaDex (CDXC) United States $0.301B 0.00
IBio (IBIO) United States $0.290B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.284B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Selecta Biosciences (SELB) United States $0.277B 0.00
Starpharma Holdings (SPHRY) Australia $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Verastem (VSTM) United States $0.261B 0.00
NextCure (NXTC) United States $0.261B 0.00
Affimed (AFMD) Germany $0.255B 0.00
DBV Technologies S.A (DBVT) France $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.251B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Dyadic (DYAI) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.233B 0.00
Celldex Therapeutics (CLDX) United States $0.230B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.223B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
Exicure (XCUR) United States $0.200B 0.00
Aduro Biotech (ADRO) United States $0.200B 0.00
XOMA (XOMA) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 9.30
Nymox Pharmaceutical (NYMX) Canada $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Cyclerion Therapeutics (CYCN) United States $0.179B 0.00
Aptinyx (APTX) United States $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.170B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Aytu Bioscience (AYTU) United States $0.158B 0.00
Bellus Health (BLU) Canada $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
TELA Bio (TELA) United States $0.150B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
VolitionRX (VNRX) United States $0.139B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.137B 0.00
Gritstone Oncology (GRTS) United States $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.129B 0.00
Cardiff Oncology (CRDF) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 6.45
Palatin Technologies (PTN) United States $0.127B 3.25
Lumos Pharma (LUMO) United States $0.125B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
CorMedix Inc (CRMD) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.104B 0.00
Antibe Therapeutics (ATBPF) Canada $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
Organovo Holdings (ONVO) United States $0.090B 0.00
AquaBounty Technologies (AQB) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
AnPac Bio-Medical Science (ANPC) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.075B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 90.00
Aerpio Pharmaceuticals (ARPO) United States $0.062B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
Genetic Technologies (GENE) Australia $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Novogen (KZIA) Australia $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Spherix (AIKI) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Chanticleer Holdings (SONN) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00